213 related articles for article (PubMed ID: 10360941)
1. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
2. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor.
Stamps SL; Fitzgerald MC; Whitman CP
Biochemistry; 1998 Jul; 37(28):10195-202. PubMed ID: 9665726
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
[TBL] [Abstract][Full Text] [Related]
5. Some insights into the stereochemistry of inhibition of macrophage migration inhibitory factor with 2-fluoro-p-hydroxycinnamate and its analogues from molecular dynamics simulations.
Zhuang S; Zou J; Jiang Y; Mao X; Zhang B; Liu H; Yu Q
J Med Chem; 2005 Nov; 48(23):7208-14. PubMed ID: 16279779
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor by 2-oxo-4-phenyl-3-butynoate.
Golubkov PA; Johnson WH; Czerwinski RM; Person MD; Wang SC; Whitman CP; Hackert ML
Bioorg Chem; 2006 Aug; 34(4):183-99. PubMed ID: 16780921
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 A resolution: analysis and implications for the mechanism of inactivation and catalysis.
Taylor AB; Czerwinski RM; Johnson WH; Whitman CP; Hackert ML
Biochemistry; 1998 Oct; 37(42):14692-700. PubMed ID: 9778344
[TBL] [Abstract][Full Text] [Related]
8. Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.
McLean LR; Zhang Y; Li H; Choi YM; Han Z; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2010 Mar; 20(6):1821-4. PubMed ID: 20185308
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.
Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R
Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants.
Stamps SL; Taylor AB; Wang SC; Hackert ML; Whitman CP
Biochemistry; 2000 Aug; 39(32):9671-8. PubMed ID: 10933783
[TBL] [Abstract][Full Text] [Related]
11. Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism.
Soares T; Goodsell D; Ferreira R; Olson AJ; Briggs JM
J Mol Recognit; 2000; 13(3):146-56. PubMed ID: 10867710
[TBL] [Abstract][Full Text] [Related]
12. A kinetic and stereochemical investigation of the role of lysine-32 in the phenylpyruvate tautomerase activity catalyzed by macrophage migration inhibitory factor.
Johnson WH; Czerwinski RM; Stamps SL; Whitman CP
Biochemistry; 1999 Nov; 38(48):16024-33. PubMed ID: 10625471
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of a macrophage migration inhibitory factor homologue from the marine cyanobacterium Prochlorococcus marinus .
Wasiel AA; Rozeboom HJ; Hauke D; Baas BJ; Zandvoort E; Quax WJ; Thunnissen AM; Poelarends GJ
Biochemistry; 2010 Sep; 49(35):7572-81. PubMed ID: 20715791
[TBL] [Abstract][Full Text] [Related]
14. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
15. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Swope M; Sun HW; Blake PR; Lolis E
EMBO J; 1998 Jul; 17(13):3534-41. PubMed ID: 9649424
[TBL] [Abstract][Full Text] [Related]
16. Ketone bodies affect the enzymatic activity of macrophage migration inhibitory factor.
Garai J; Lóránd T; Molnár V
Life Sci; 2005 Aug; 77(12):1375-80. PubMed ID: 15893774
[TBL] [Abstract][Full Text] [Related]
17. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
[TBL] [Abstract][Full Text] [Related]
18. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
19. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
[TBL] [Abstract][Full Text] [Related]
20. Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
Trivedi-Parmar V; Robertson MJ; Cisneros JA; Krimmer SG; Jorgensen WL
ChemMedChem; 2018 Jun; 13(11):1092-1097. PubMed ID: 29575754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
